XNAS
IAM
, Last price
USD
Name
Iambic Therapeutics, Inc.
Chart & performance
P/E
—
P/S
—
EPS
Div yield, %
—
Shs. 5Y
—
Rev. 5Y
%
Revenues
Net income
CFO
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Iambic Therapeutics, Inc. develops AI driven platform for drug discovery. It combines proprietary AI-driven platforms with the expertise of experienced drug discovery scientists to identify, design, and optimize novel therapeutic candidates across a range of disease areas. The company was founded by Thomas Miller and Fred Manby on October 14, 2019 and is headquartered in San Diego, CA.
Key people
Michael Secora
Chief Financial Officer and Chief Corporate Development Officer · since 2025
Pete Olson
Chief Scientific Officer · since 2025
Chao Zhang
Chief Scientific Officer
Tabbert Teng
Vice President - Finance
Naren Gupta
Director
Fred Manby
Chief Technology Officer, Director
Chief Executive Officer, Director
Jacob Vogelstein
Director
Valuation
No data to show